search
Back to results

Implementing a Digitally-enabled Community Health Worker Intervention for Patients With Heart Failure

Primary Purpose

Heart Failure,Congestive

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Digitally-enabled CHW Care
Usual CHW Care
Sponsored by
Massachusetts General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Heart Failure,Congestive focused on measuring community health worker care, digital platform, remote monitoring, readmissions, clinical trial, heart failure

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age ≥18 years
  • HF diagnosis
  • English proficiency
  • Residence within 30 miles of MGH
  • Being cared for by a cardiologist or primary care provider who manages their HF
  • Current use and ownership of a smart phone

Exclusion Criteria:

  • Cognitive deficits that prevent digital or human engagement
  • Lack of health insurance
  • Invoked health proxy or guardianship status
  • History of smart phone use

Sites / Locations

  • Massachusetts General HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention

Usual CHW Care

Arm Description

Patients identified by the MGH readmission database and the EHR as eligible for the study will be enrolled. Participants will be paired with a community health worker and oriented to the digital platform ( mobile app, digital weight scale, digital blood pressure monitor, biosensor with armband). Participants will have access to the community health worker and the digital platform throughout the 30-day study interval.

Patients identified by the MGH readmission database and the EHR as eligible for the study will be enrolled. Participants will be paired with a community health worker. Participants will have access to the community health worker throughout the 30-day study interval.

Outcomes

Primary Outcome Measures

Intervention Acceptability
Proportion of patients indicating that they would be willing to use the intervention again
Intervention Feasibility
Proportion of patients that used the intervention during the study period
Heart Failure Knowledge
Proportion of patients with improved perceived heart failure knowledge ( per an internally validated knowledge questionnaire) after the intervention

Secondary Outcome Measures

30-day readmission rate
Proportion of patients readmitted to the hospital within 30-days after hospital discharge
30-day missed appointment rate
Proportion of patients missing PCP or specialty appointments within 30-days after hospital discharge
30-day Emergency Department visit rate
Proportion of patients returning to the Emergency Department within 30-days of hospital discharge

Full Information

First Posted
November 10, 2021
Last Updated
November 2, 2022
Sponsor
Massachusetts General Hospital
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT05130008
Brief Title
Implementing a Digitally-enabled Community Health Worker Intervention for Patients With Heart Failure
Official Title
Implementing a Digitally-enabled Community Health Worker Intervention for Patients With Heart Failure
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
August 12, 2022 (Actual)
Primary Completion Date
August 30, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts General Hospital
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to assess the acceptability, feasibility, and preliminary effectiveness of implementing a 30-day digitally-enabled community health worker intervention compared to usual care with a community health worker in reducing heart failure 30-day readmissions within a pilot randomized controlled trial.
Detailed Description
Heart failure (HF) is a highly prevalent disease in the United States, with elevated morbidity and mortality. Nearly 6.2 million people in the US are affected by HF and this number is expected to rise to 8.5 million by 2030. Total direct medical costs of HF, mostly generated by inpatient hospitalizations, are estimated to increase from $21 billion in 2012 to $53 billion by 2030. HF is the leading cause of 30-day readmissions in the US; a quarter of these are considered to be preventable. Most patients with HF are readmitted to hospital medicine services for non-HF co-morbidities (e.g. pneumonia) with clinical, social, and behavioral factors driving readmissions. Despite numerous interventions designed to prevent readmissions, including telemetry monitoring, only marginal HF outcome improvement has been observed. HF readmission rates remain elevated and could be prevented by a multidisciplinary approach promoting better connections to and communication with clinical care teams while addressing social and behavioral barriers to HF care. One approach that has demonstrated improved chronic disease outcomes by addressing social, behavioral, and basic clinical barriers to care- and has yet to be formally studied in HF populations- is community health workers (CHWs). CHWs are members of clinical teams who address social, economic, educational, behavioral, and basic clinical factors influencing health outcomes while fostering patient connections to care teams. CHW care delivery is one of a few interventions shown to reduce readmissions in patients with chronic disease. CHWs have basic clinical knowledge of specific conditions, along with a skillset designed to address social and behavioral drivers of health outcomes like 30-day readmissions. However, CHW care is challenged by key factors, including intensive 1:1 care delivery, limiting its scale and efficiency. In 2016, a biotechnology company launched a HF digital platform within a mobile phone application to help reduce 30-day readmissions in patients with HF by 1) leveraging artificial intelligence to minimize false alarms in biometric monitoring, 2) promoting early identification of decline in HF patients, and 3) encouraging digital and in-person communication between patients and care teams. In preliminary findings, digital platform clinical trial data has shown promise in reducing HF 30-day readmissions. This study will investigate the effectiveness of this platform in combination with CHW care in reducing readmissions for medically and socially complex patients with HF. Through a partnership with the digital platform creators, our team has helped develop a prototype for patients with HF cared for by CHWs ("digitally-enabled" CHW care). Specifically, the aim of this proposal are to assess the acceptability, feasibility, and preliminary effectiveness of implementing a digitally-enabled CHW intervention compared to CHW care to reduce HF 30-day readmissions within a pilot RCT (n=50) My central hypothesis is that pairing patients with a digitally-enabled CHW intervention that addresses social and behavioral barriers to HF care, promotes communication with clinical care teams, and improves CHW efficiency will reduce 30-day readmissions while improving patient engagement with HF care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure,Congestive
Keywords
community health worker care, digital platform, remote monitoring, readmissions, clinical trial, heart failure

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Controlled Trial
Masking
Outcomes Assessor
Masking Description
The outcomes assessor team will be blinded to the intervention assignments of participants. Due to the nature of the intervention, the participants, the investigator, and the care providers are unable to be blinded to the participant assignments.
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Patients identified by the MGH readmission database and the EHR as eligible for the study will be enrolled. Participants will be paired with a community health worker and oriented to the digital platform ( mobile app, digital weight scale, digital blood pressure monitor, biosensor with armband). Participants will have access to the community health worker and the digital platform throughout the 30-day study interval.
Arm Title
Usual CHW Care
Arm Type
Active Comparator
Arm Description
Patients identified by the MGH readmission database and the EHR as eligible for the study will be enrolled. Participants will be paired with a community health worker. Participants will have access to the community health worker throughout the 30-day study interval.
Intervention Type
Other
Intervention Name(s)
Digitally-enabled CHW Care
Intervention Description
Patients will be paired with a CHW and be encouraged to wear the arm biosensor continuously, take blood pressure daily, respond to short symptom assessments daily or every other day, complete weekly life quality surveys, watch weekly HF educational videos and engage in digital (e.g., video visit) and phone-based, and in-person CHW interactions. Each participant will have access to the digital platform and CHW staff during their hospitalization and for the 30 days following discharge for a typical study duration of approximately 32-35 days. Participants will complete questionnaires at the time of enrollment and at study end. Participants will also complete exit interviews in-person or via phone after the study ends.
Intervention Type
Behavioral
Intervention Name(s)
Usual CHW Care
Intervention Description
Patients will be paired with a CHW for 30-days. Participants will complete questionnaires at the time of enrollment and at study end. Participants will also complete exit interviews in-person or via phone after the study ends.
Primary Outcome Measure Information:
Title
Intervention Acceptability
Description
Proportion of patients indicating that they would be willing to use the intervention again
Time Frame
12 months
Title
Intervention Feasibility
Description
Proportion of patients that used the intervention during the study period
Time Frame
12 months
Title
Heart Failure Knowledge
Description
Proportion of patients with improved perceived heart failure knowledge ( per an internally validated knowledge questionnaire) after the intervention
Time Frame
12 months
Secondary Outcome Measure Information:
Title
30-day readmission rate
Description
Proportion of patients readmitted to the hospital within 30-days after hospital discharge
Time Frame
12 months
Title
30-day missed appointment rate
Description
Proportion of patients missing PCP or specialty appointments within 30-days after hospital discharge
Time Frame
12 months
Title
30-day Emergency Department visit rate
Description
Proportion of patients returning to the Emergency Department within 30-days of hospital discharge
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Patient Satisfaction
Description
Proportion of patients per a internally validated satisfaction scale that were very or somewhat satisfied with intervention use
Time Frame
12 months
Title
Medication Compliance
Description
Proportion of patients demonstrating improved medication compliance on the MMAS after the intervention
Time Frame
12 months
Title
Quality of Life (patient perceptions and attitudes, functionality and mobility)
Description
Proportion of patients demonstrating improved perceived quality of life on the KCCQ after the intervention
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age ≥18 years HF diagnosis English proficiency Residence within 30 miles of MGH Being cared for by a cardiologist or primary care provider who manages their HF Current use and ownership of a smart phone Exclusion Criteria: Cognitive deficits that prevent digital or human engagement Lack of health insurance Invoked health proxy or guardianship status History of smart phone use
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jocelyn A Carter, MD
Phone
617-726-4801
Email
jcarter0@partners.org
First Name & Middle Initial & Last Name or Official Title & Degree
Anne Walton, RN
Phone
617-726-4801
Email
awalton@partners.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jocelyn Carter, MD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jocelyn Carter, MD, MPH
Phone
617-726-2000
Email
jcarter0@partners.org
First Name & Middle Initial & Last Name & Degree
Natalia Swack, BS
Phone
6177264801
Email
nswack@partners.org

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The data can be available by request only after academic journal publication. Any formal requests should be sent by external research teams and will be reviewed by the corresponding author.
IPD Sharing Time Frame
The data will become available upon request after academic journal publication.
IPD Sharing Access Criteria
Access criteria will be determined and confirmed by the corresponding author upon review of the formal data request.
Citations:
PubMed Identifier
23616602
Citation
Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Pina IL, Trogdon JG; American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013 May;6(3):606-19. doi: 10.1161/HHF.0b013e318291329a. Epub 2013 Apr 24.
Results Reference
background
PubMed Identifier
23151591
Citation
McHugh MD, Ma C. Hospital nursing and 30-day readmissions among Medicare patients with heart failure, acute myocardial infarction, and pneumonia. Med Care. 2013 Jan;51(1):52-9. doi: 10.1097/MLR.0b013e3182763284.
Results Reference
background
PubMed Identifier
29101131
Citation
Abdel-All M, Putica B, Praveen D, Abimbola S, Joshi R. Effectiveness of community health worker training programmes for cardiovascular disease management in low-income and middle-income countries: a systematic review. BMJ Open. 2017 Nov 3;7(11):e015529. doi: 10.1136/bmjopen-2016-015529.
Results Reference
background
PubMed Identifier
29703724
Citation
Spencer MS, Kieffer EC, Sinco B, Piatt G, Palmisano G, Hawkins J, Lebron A, Espitia N, Tang T, Funnell M, Heisler M. Outcomes at 18 Months From a Community Health Worker and Peer Leader Diabetes Self-Management Program for Latino Adults. Diabetes Care. 2018 Jul;41(7):1414-1422. doi: 10.2337/dc17-0978. Epub 2018 Apr 27.
Results Reference
background

Learn more about this trial

Implementing a Digitally-enabled Community Health Worker Intervention for Patients With Heart Failure

We'll reach out to this number within 24 hrs